Nasdaq:US$13.75 (+0.38) | HKEX:HK$22.40 (+1.10) | AIM:£2.11 (+0.09)
搜索
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2010-10-16

ISSX 2011: Preclinical assessment of the absorption, distribution, metabolism and excretion of HMPL-013 (fruquintinib), a novel potent and specific VEGFR inhibitor